Prevention of Cardiac and Vascular Events in Patients With NGT/IGT.

PHASE3CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

November 30, 2004

Study Completion Date

November 30, 2006

Conditions
Cardiovascular Disease
Interventions
DRUG

L-arginine

Trial Locations (1)

20132

Scientific Institute San Raffaele, Milan

All Listed Sponsors
lead

IRCCS San Raffaele

OTHER

NCT00408577 - Prevention of Cardiac and Vascular Events in Patients With NGT/IGT. | Biotech Hunter | Biotech Hunter